Published in Radiother Oncol on March 01, 1988
Proton Therapy for Lymph Nodes in Breast Cancer (BR01) | NCT01365845
Adjuvant radiotherapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials. Radiat Oncol (2013) 1.17
Review of deep inspiration breath-hold techniques for the treatment of breast cancer. J Med Radiat Sci (2015) 0.93
The natural history of human breast cancer. The relationship between involvement of axillary lymph nodes and the initiation of distant metastases. Br J Cancer (1989) 0.88
Radiation pneumonitis in breast cancer patients who received radiotherapy using the partially wide tangent technique after breast conserving surgery. J Breast Cancer (2012) 0.84
The Metastatic Rate of Internal Mammary Lymph Nodes When Metastasis of Internal Mammary Lymph Node Is Suspected on PET/CT. J Breast Cancer (2013) 0.81
Operable breast cancer of the inner hemisphere is associated with poor survival. J Breast Cancer (2015) 0.77
Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res (1971) 13.16
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol (1989) 5.44
Low-dose risk assessment. Radiat Res (2007) 2.88
Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Lancet (1997) 2.80
Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer (1982) 2.71
Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab (1986) 2.70
Follow up in breast cancer. BMJ (1995) 2.50
Repair of potentially lethal radiation damage in vitro and in vivo. Radiology (1973) 2.43
Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol (2003) 2.42
Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol (1995) 2.29
Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study. J Clin Oncol (1999) 2.25
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer. J Clin Oncol (1996) 2.17
The link between local recurrence and distant metastases in human breast cancer. Int J Radiat Oncol Biol Phys (1999) 2.10
Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival. Cancer J Sci Am (1997) 2.09
Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol (1996) 2.08
Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma. GROP and the French Cancer Center's Lung Group. Int J Radiat Oncol Biol Phys (1990) 2.03
Prognostic importance of low c-erbB2 expression in breast tumors. J Natl Cancer Inst (1998) 2.00
Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience. Br J Cancer (1998) 1.96
Prognostic factors in primary breast sarcomas: a series of patients with long-term follow-up. J Clin Oncol (2003) 1.96
Cell proliferation kinetics in five human solid tumors. Cancer (1968) 1.92
Relation between the pathological nature and the growth rate of human tumors. Eur J Cancer (1971) 1.92
Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am Coll Surg (1998) 1.79
Risk factors for brain relapse in patients with metastatic breast cancer. Ann Oncol (2004) 1.79
Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma. Cancer (2001) 1.78
Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys (1991) 1.77
Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative study. Cancer (1976) 1.75
Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys (1985) 1.74
Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer (1984) 1.71
Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer. N Engl J Med (1993) 1.69
Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less. The experience of the Institut Gustave-Roussy. Cancer (1984) 1.69
The relationship between growth rate, labelling index and histological type of human solid tumours. Eur J Cancer (1973) 1.68
Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer (1985) 1.66
Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer. Cancer (1983) 1.65
[Growth rate and natural history of breast cancer]. Bull Cancer (1976) 1.61
Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol (1989) 1.60
A genomewide suppressor and enhancer analysis of cdc13-1 reveals varied cellular processes influencing telomere capping in Saccharomyces cerevisiae. Genetics (2008) 1.58
Can internal mammary chain treatment decrease the risk of death for patients with medial breast cancers and positive axillary lymph nodes? Cancer (1990) 1.55
Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy. Ann Oncol (2005) 1.54
The long-term prognostic significance of the thymidine labelling index in breast cancer. Int J Cancer (1984) 1.51
In vitro study of cellular immunity against autochthonous human cancer. Int J Cancer (1972) 1.51
Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med (1996) 1.49
L.H. Gray Medal lecture: cell kinetics and radiation oncology. Int J Radiat Oncol Biol Phys (1982) 1.46
Risk factors for failure of immediate breast reconstruction with prosthesis after total mastectomy for breast cancer. Cancer (1992) 1.46
Pathology reporting of breast cancer: trends in 1989-1999, following the introduction of mammographic screening in Western Australia. Pathology (2005) 1.44
Radiotherapy after ovarian transposition: ovarian function and fertility preservation. Int J Radiat Oncol Biol Phys (1993) 1.44
[Adenocarcinomas of the breast in women under 30]. Bull Cancer (1973) 1.42
Adjuvant chemotherapy in early breast cancer and incidence of new primary malignancies. Lancet (1991) 1.42
Presence of mutations in all three ras genes in human thyroid tumors. Oncogene (1990) 1.42
Effectiveness of preoperative chemotherapy in Wilms' tumor: results of an International Society of Paediatric Oncology (SIOP) clinical trial. J Clin Oncol (1983) 1.39
Wilms' tumor: natural history and prognostic factors: a retrospective study of 248 cases treated at the Institut Gustave-Roussy 1952-1967. Cancer (1976) 1.39
Kinetics of cell proliferation of an experimental tumor. Cancer Res (1967) 1.38
Pre-operative chemo-radiotherapy in locally advanced rectal cancer: is this the way of future management? Australas Radiol (1999) 1.38
Possible cohort effects in studies on oral contraceptive use and breast cancer. Br J Cancer (1985) 1.38
High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas. J Clin Oncol (1995) 1.36
Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance. Int J Cancer (1989) 1.35
Beta(2)-adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension (2000) 1.35
Is there a place for radiation therapy in the management of hepatoblastomas and hepatocellular carcinomas in children? Int J Radiat Oncol Biol Phys (1992) 1.34
Kinetic parameters and the course of the disease in breast cancer. Cancer (1981) 1.30
Sugars and flowering in the grapevine (Vitis vinifera L.). J Exp Bot (2008) 1.30
Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment. Br J Cancer (2003) 1.29
Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials. Ann Oncol (2007) 1.29
External radiotherapy in thyroid cancers. Cancer (1985) 1.28
Ductal carcinoma in situ: MR imaging-histopathologic correlation. Radiology (1995) 1.27
Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen. Br Med J (Clin Res Ed) (1982) 1.25
Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients. Arch Intern Med (1988) 1.25
Cockroaches as carriers of bacteria in multi-family dwellings. Epidemiol Infect (1992) 1.22
The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. Eur J Cancer (2004) 1.22
Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer. J Clin Oncol (1999) 1.21
Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma. Cancer (1988) 1.20
[Could treatments with beta-blockers be associated with a reduction in cancer risk?]. Rev Epidemiol Sante Publique (2004) 1.19
Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis. J Crohns Colitis (2011) 1.18
Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B-cell lymphoma. Int J Cancer (1987) 1.17
Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis. Oncogene Res (1988) 1.16
Is it useful to remove internal mammary nodes in operable breast cancer? Eur J Surg Oncol (1987) 1.15